Kangstem Biotech Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.087x

Kangstem Biotech Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has a cash flow conversion efficiency ratio of -0.087x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.93 Billion ≈ $-3.34 Million USD) by net assets (₩56.56 Billion ≈ $38.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kangstem Biotech Co. Ltd (2015–2025)

Cash flow conversion efficiency of Kangstem Biotech Co. Ltd from 2015 to 2025. This chart illustrates how Kangstem Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 217730 stock price and chart for real-time trading data and today's change.

Kangstem Biotech Co. Ltd Cash Flow Conversion Ratio Explained

Kangstem Biotech Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kangstem Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their cash flow conversion efficiency. Also see 217730 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bellevue Group AG SW:BBN	0.150x
Norsk Titanium AS OL:NTI	-0.732x
UVAT Technology Co Ltd TWO:3580	0.047x
Southern Hydropower JSC VN:SHP	0.058x
STCube Inc KQ:052020	-0.065x
PT Mandiri Herindo Adiperkasa Tbk JK:MAHA	-0.050x
Vardhman Holdings Limited NSE:VHL	0.000x
Excel Industries Limited NSE:EXCELINDUS	0.010x

Annual Cash Flow Conversion Efficiency for Kangstem Biotech Co. Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Kangstem Biotech Co. Ltd from 2015 to 2025. Review free cash flow generation of Kangstem Biotech Co. Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩69.06 Billion ≈ $46.80 Million	₩-11.68 Billion ≈ $-7.91 Million	-0.169x	+61.55%
2024-12-31	₩43.18 Billion ≈ $29.26 Million	₩-18.99 Billion ≈ $-12.87 Million	-0.440x	-18.65%
2023-12-31	₩44.52 Billion ≈ $30.17 Million	₩-16.50 Billion ≈ $-11.18 Million	-0.371x	+7.15%
2022-12-31	₩47.26 Billion ≈ $32.03 Million	₩-18.86 Billion ≈ $-12.78 Million	-0.399x	-59.89%
2021-12-31	₩68.07 Billion ≈ $46.13 Million	₩-16.99 Billion ≈ $-11.52 Million	-0.250x	+7.92%
2020-12-31	₩51.62 Billion ≈ $34.98 Million	₩-13.99 Billion ≈ $-9.48 Million	-0.271x	-43.92%
2019-12-31	₩70.72 Billion ≈ $47.93 Million	₩-13.32 Billion ≈ $-9.03 Million	-0.188x	+21.73%
2018-12-31	₩47.69 Billion ≈ $32.32 Million	₩-11.48 Billion ≈ $-7.78 Million	-0.241x	+46.94%
2017-12-31	₩23.47 Billion ≈ $15.91 Million	₩-10.65 Billion ≈ $-7.22 Million	-0.454x	-33.67%
2016-12-31	₩22.98 Billion ≈ $15.57 Million	₩-7.80 Billion ≈ $-5.28 Million	-0.339x	-89.64%
2015-12-31	₩21.24 Billion ≈ $14.39 Million	₩-3.80 Billion ≈ $-2.58 Million	-0.179x	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$119.13 Million

₩175.79 Billion KRW

Market Cap Rank

#18342 Global

#809 in Korea

Share Price

₩1869.00

Change (1 day)

-2.20%

52-Week Range

₩1397.00 - ₩4615.00

All Time High

₩18836.30